ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	46.18	45.92	20.1	23.14	27.62	54.11
Short-Term Investments	-	-	-	-	9.87	-
Cash & Short-Term Investments	46.18	45.92	20.1	23.14	37.49	54.11
Cash Growth	20.83%	128.43%	-13.12%	-38.27%	-30.72%	169.21%
Receivables	9.08	7.26	5.36	3.94	2.71	2.34
Inventory	9.77	8.36	6.86	7.91	9.3	4.94
Prepaid Expenses	1.68	2.06	1.04	1.18	1.35	0.51
Other Current Assets	-	-	-	-	0.33	-
Total Current Assets	66.71	63.6	33.36	36.17	51.18	61.89
Property, Plant & Equipment	24.32	11.05	5.09	4.95	2.7	2.78
Goodwill	7.47	7.47	-	-	-	-
Other Intangible Assets	12.41	13.92	-	1.04	1.03	0.27
Other Long-Term Assets	1.81	1.7	0.74	0.5	0.58	0.64
Total Assets	112.73	97.75	39.19	42.66	55.49	65.58

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.06	1.26	1.34	0.39	0.27	0.43
Accrued Expenses	7.06	7.15	6.34	4	4.89	3.14
Current Portion of Leases	0.2	0.69	0.56	0.42	0.56	0.51
Current Unearned Revenue	1.55	1.67	2.12	2.61	1.07	0.68
Total Current Liabilities	9.87	10.77	10.35	7.43	6.79	4.75
Long-Term Debt	50.84	49.08	-	9.95	9.89	9.84
Long-Term Leases	22.66	8.46	3.01	3.57	1.53	1.94
Long-Term Unearned Revenue	0.43	0.58	0.44	0.54	0.39	0.26
Long-Term Deferred Tax Liabilities	0.31	0.35	-	-	-	-
Other Long-Term Liabilities	1.36	0.49	-	-	-	-
Total Liabilities	85.46	69.73	13.8	21.49	18.6	16.79

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.32	0.29	0.28	0.25	0.25	0.24
Additional Paid-In Capital	269.64	239	216.48	193.38	187.01	182.48
Retained Earnings	-245.26	-216.91	-191.37	-172.46	-150.37	-133.93
Comprehensive Income & Other	2.57	5.64	-	-	-	-
Shareholders' Equity	27.27	28.02	25.39	21.17	36.89	48.79
Total Liabilities & Equity	112.73	97.75	39.19	42.66	55.49	65.58

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	73.7	58.23	3.57	13.94	11.99	12.28
Net Cash (Debt)	-27.52	-12.31	16.54	9.2	25.5	41.83
Net Cash Growth	-	-	79.76%	-63.93%	-39.02%	-
Net Cash Per Share	-0.92	-0.43	0.61	0.37	1.05	2.02
Filing Date Shares Outstanding	32.05	29.66	27.63	26.98	24.61	23.69
Total Common Shares Outstanding	32.05	29.37	27.62	24.65	24.58	23.67
Working Capital	56.85	52.84	23.01	28.74	44.39	57.14
Book Value Per Share	0.85	0.95	0.92	0.86	1.50	2.06
Tangible Book Value	7.38	6.63	25.39	20.13	35.86	48.52
Tangible Book Value Per Share	0.23	0.23	0.92	0.82	1.46	2.05
Machinery	-	3.85	2.86	1.85	2.37	2.23
Leasehold Improvements	-	0.49	0.49	0.49	0.2	0.2

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error